Targeted inhibition of E. coli adhesion using antisense oligonucleotides: an approach to combat bacteria via CsrB...

Area of Science:

• Microbiology
• Molecular Biology
• Antimicrobial Therapy

Background:

• Biofilms, prevalent bacterial structures, are linked to severe health issues like diarrhea and kidney failure.
• The Carbon Storage Regulator A (CsrA) protein and its regulatory RNAs (CsrB, CsrC) are crucial for bacterial processes including biofilm formation.
• Targeting these regulatory pathways presents a potential strategy for combating bacterial infections.

Purpose of the Study:

• To design and evaluate a novel antisense oligonucleotide (ASO) targeting the csrB gene in Escherichia coli.
• To assess the efficacy of ASO-mediated gene silencing on biofilm formation and bacterial adhesion.
• To explore the potential of ASOs as a therapeutic approach against biofilm-associated infections.

Main Methods:

• Design of a specific antisense oligonucleotide (ASO) to target the csrB gene.
• Delivery of the ASO using polyethyleneimine (PEI) in Escherichia coli strains.
• Evaluation of ASO efficacy through quantitative real-time PCR, colony-forming unit (CFU) assays, and crystal violet staining.

Main Results:

• Significant reduction in csrB and csrA gene expression in the treated O42 strain (p < 0.05).
• Notable decrease in csrB expression in the O157 strain (p = 0.041).
• Significant reduction in biofilm formation and bacterial adhesion in the treated O42 strain (p < 0.05).

Conclusions:

• Antisense oligonucleotides targeting csrB are effective in reducing gene expression and biofilm formation in Escherichia coli.
• ASO-mediated silencing of csrB disrupts key regulatory pathways involved in bacterial adhesion and biofilm development.
• This study highlights the potential of ASOs targeting small regulatory RNAs as a novel therapeutic strategy for managing biofilm-associated infections.